Literature DB >> 8539387

Biliary stones and sludge in liver transplant patients: a 13-year experience.

R Sheng1, C B Ramirez, A B Zajko, W L Campbell.   

Abstract

PURPOSE: To determine the prevalence, radiologic features, and clinical significance of bile duct filling defects (BDFDs) in liver transplant recipients studied with cholangiography.
MATERIALS AND METHODS: During 13 years, 4,100 cholangiograms were obtained in 1,650 patients. All studies showing BDFD suggestive of stones, sludge, cast, or necrotic debris were retrospectively evaluated.
RESULTS: The prevalence of BDFD was 5.7% (n = 94). On the basis of cholangiographic appearance, BDFDs were categorized as sludge or cast in 53 grafts (56%), stones in 32 (34%), and necrotic debris in nine (10%). Forty-three patients (46%) underwent surgical biliary reconstruction, while 14 (15%) underwent interventional radiologic treatments. Twenty-four of 32 stones (75%) were treated with surgical reconstruction, compared with 31% (19 of 62 grafts) of other BDFDs (P < .0001). Necrotic debris and sludge were associated with hepatic artery occlusion in seven of nine (78%) and 16 of 53 (30%) grafts, respectively.
CONCLUSION: Stones and sludge are relatively infrequent after liver transplantation but are associated with high morbidity. Surgical or interventional radiologic treatments are usually performed. Bile duct stones are usually treated with surgical biliary reconstruction. While debris and bile duct necrosis are due to ischemia from hepatic artery occlusion, sludge may also have an ischemic pathogenesis in some cases.

Entities:  

Mesh:

Year:  1996        PMID: 8539387     DOI: 10.1148/radiology.198.1.8539387

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Management of biliary complications following orthotopic liver transplantation.

Authors:  Andrew E Scanga; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2007-03

2.  Management of biliary complications after orthotopic liver transplantation: the role of endoscopy.

Authors:  Maria-C Londoño; Domingo Balderramo; Andrés Cárdenas
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

3.  Biliary casts after liver transplantation: morphology and biochemical analysis.

Authors:  Yu-Long Yang; Cheng Zhang; Mei-Ju Lin; Li-Jun Shi; Hong-Wei Zhang; Jing-Yi Li; Qiang Yu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

4.  Interventional radiology: management of biliary complications of liver transplantation.

Authors:  Nishita Kothary; Aalpen A Patel; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

Review 5.  Imaging of the transplant liver.

Authors:  Paul Sheppard Babyn
Journal:  Pediatr Radiol       Date:  2010-04

Review 6.  Endoscopic management of post-liver transplant biliary complications.

Authors:  Mohit Girotra; Kaartik Soota; Jagpal S Klair; Shyam M Dang; Farshad Aduli
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

Review 7.  Sonography of liver transplantation.

Authors:  Ekta Maheshwari; Mitchell E Tublin
Journal:  Abdom Radiol (NY)       Date:  2020-10-12

8.  Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation.

Authors:  N Sasahira; M Tada; H Yoshida; R Tateishi; S Shiina; K Hirano; H Isayama; N Toda; Y Komatsu; T Kawabe; M Omata
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 9.  Imaging of biliary disorders in children.

Authors:  Céline Rozel; Laurent Garel; Françoise Rypens; Loïc Viremouneix; Chantale Lapierre; Jean Claude Décarie; Josée Dubois
Journal:  Pediatr Radiol       Date:  2010-09-24

10.  Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation.

Authors:  H J Schlitt; P N Meier; B Nashan; K J Oldhafer; K Boeker; P Flemming; R Raab; M P Manns; R Pichlmayr
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.